Skip to main content
. 2011 Sep 14;29(8):501–510. doi: 10.3109/07357907.2011.606248

Figure 5 .

Figure 5 

Cytotoxicity of the expanded CTL against various tumor cell lines. CD8+ T cells stimulated with MVAp53 and restimulated for 2 sequential IVS with the human p53 peptide library were used as an effector cells in a standard 4-hr CRA. (a) Cytotoxic activity was assessed against SAOS-2 (osteosarcoma cell line, p53 null, and HLA-A2+) and SAOS–p53 (p53 transfected SAOS-2 cell line). (b) Cytotoxic activity was assessed against mammary carcinoma cell lines, MDA-MB231 (p53+ and HLA-A2+), and SK-BR3 (p53+ and HLA-A2-). *p < .05, **p < .01 by two-tailed unpaired t test.